QRxPharma Limited

FDA’s Division of Anesthesia, Analgesia and Addiction Products will be moving into the post- Zohydro era with a new director. Sharon Hertz, the deputy in the division, was elevated to Acting Director

FDA’s Division of Anesthesia, Analgesia & Addiction Products will be moving into the post- Zohydro era with a new director. Sharon Hertz, the deputy in the division, was elevated to Acting Director a

Company Changes New At The Helm This Month ADAMS , Jason To: Epic Sciences Inc. , VP, Bus. Dev. (May) From: Ventana Medical Systems Inc., Companion Diagnostics Bus. Dev. Group Phone: 858-356-66

QRxPharma Ltd. will need another clinical trial to move forward with Moxduo (morphine/oxycodone), both to satisfy FDA’s regulatory requirements on safety and efficacy but also to address larger so